PROGRAMME

PROGRAMME 2018

Get ready for two jam-packed days of health tech goodness, from applied AI case studies, to announcements from the tech giants, to nitty-gritty coding workshops, and of course, passionate debate on ethics and AI4good in health.

INTELLIGENT HEALTH 2018 PROGRAMME

    Active Filters
  • Wednesday 12th
  • 07:30 - 09:00
    REGISTRATION
  • 09:00 - 09:10
    WELCOME - IH OPENING Sarah Porter, CEO and Founder, InspiredMinds
    Baschi Dürr, Minister for Justice and Security of the Canton of Basel-Stadt, Governing Council of the Canton of Basel-Stadt
    Dr. Patrice Matchaba, Group Head Global Health & Corporate Responsibility, Novartis
    Babita Sharma, Television Presenter, BBC
    TBC

    A welcome from Sarah Porter, CEO and Founder of InspiredMinds and Babita Sharma, Television Presenter at the BBC

    • Sarah Porter, CEO and Founder, InspiredMinds

      Sarah Porter has launched 21 b2b and b2c technology products in 11 countries since 1996 and has a renowned reputation for taking ideas from concept to market with subsequent significant growth globally. Emerging tech / AI / Medtech / Singularity / existentialism is where her core experience lies and she has over 20 years of commercial experience.

    • Baschi Dürr, Minister for Justice and Security of the Canton of Basel-Stadt, Governing Council of the Canton of Basel-Stadt

      Throughout his career, Baschi Dürr, lic. rer. pol. (Basel University), has worked inter alia at Neue Zürcher Zeitung, Wirz Investor Relations, F. Hoffmann-La Roche and Farner Consulting. Politically active for over 20 years, he was a member of the Basel Parliament since 2003. In 2012, aged 35, Baschi Dürr was elected to the Government of Basel.

    • Dr. Patrice Matchaba, Group Head Global Health & Corporate Responsibility, Novartis

      Patrice Matchaba, M.D., has been Global Head of Corporate Responsibility for Novartis since October 1, 2017. Dr. Matchaba most recently served as Global Head of the Cardio-Metabolic development unit at Novartis, where he led the global clinical development of the cardio-metabolic portfolio.

    • Babita Sharma, Television Presenter, BBC

      Babita Sharma is a BBC News presenter, regularly seen on the BBC News Channel, BBC World News, and presenting the show Newsday. Babita has presented the finance programme Your Money, and fronts business reports for BBC News. She has also covered economic and political stories from around the world.

  • 09:10 - 09:35
    HEADLINER - AI - the future of medicine? Bertrand Bodson, Chief Digital Officer, Novartis TBC

    Deep learning for health – what’s still missing?

    • Bertrand Bodson, Chief Digital Officer, Novartis

      Bertrand Bodson has been Chief Digital Officer of Novartis since January 1, 2018. He is a member of the Executive Committee of Novartis. From 2013 to 2017, Mr. Bodson served as chief digital and marketing officer of Sainsbury's Argos, where he led Argos’ successful transformation from a traditional catalogue business to the third-largest online retailer in the United Kingdom. Prior to that, he was executive vice president of the global digital business at EMI Music from 2010 to 2013. He co-founded Bragster.com, a social networking and content sharing website, and has also held senior roles at Amazon.

  • 09:35 - 10:00
    HEADLINER - Artificial Intelligence and the challenges for the digital transformation of health and care in Europe? Dr. Marco Marsella, Head of the Unit - DG CONNECT, European Commission
    • Dr. Marco Marsella, Head of the Unit - DG CONNECT, European Commission

      Marco Marsella is Head of Unit ‘Learning, Multilingualism and Accessibility’ in the Directorate General for Communications Networks, Content and Technology (DG CONNECT) of the European Commission.

  • 10:00 - 10:25
    HEADLINER - EXCLUSIVE LAUNCH: Why healthcare needs AI – global trends, strategies and C-level perspectives Dr. Kaveh Safavi, Senior Managing Director, Head of Global Health Practice, Accenture Health
    • Dr. Kaveh Safavi, Senior Managing Director, Head of Global Health Practice, Accenture Health

      Kaveh Safavi, M.D., J.D. is the senior managing director for Accenture’s global healthcare business. Dr. Safavi is responsible for developing and driving a growth strategy that differentiates Accenture’s offerings for providers, health insurers and public and private health systems across the globe.

  • 10:25 - 10:35
    EXCLUSIVE: XPRIZE to present Avatar competition guidelines and call for teams to register at Intelligent Health! Amir Banifatemi, AI Lead, XPRIZE
    • Amir Banifatemi, AI Lead, XPRIZE

      Amir Banifatemi has more than 25 years of experience in development and growth of emerging and transformative technologies. At XPRIZE he is the Prize Lead of the IBM Watson AI XPRIZE and has launched the Cancer XPRIZE goal. The winning Cancer XPRIZE team will develop scalable and culturally sensitive solutions to rapidly, accurately, and affordably screen for early cancers where intervention can reduce human suffering - a part of this launch will be at Intelligent Health this year.

  • 10:35 - 11:05
    REFRESHMENTS & NETWORKING
  • 11:05 - 11:30
    HEADLINER - AI won’t replace humans; it will free us up to add more value to society Steve Guise, Global Head of Informatics, Roche Pharmaceuticals
    • Steve Guise, Global Head of Informatics, Roche Pharmaceuticals

      Steve Guise has been Global Head of Informatics for Roche Pharmaceuticals since October 2016. During these nearly two years, Steve has built and led a new informatics organization focused on business partnering and driving technology innovation to address business challenges — to ultimately benefit patients.

  • 11:55 - 12:20
    HEADLINER - Saving lives with advanced analytics, machine learning and data driven thinking in hospitals José Pedro Almeida, Director of Big Data Analytics & Machine Learning, São João Hospital Centre
    • José Pedro Almeida, Director of Big Data Analytics & Machine Learning, São João Hospital Centre

      He is the Director of Big Data Analytics & Data Science of São João Hospital Center (CHSJ), the #1 public hospital center in Portugal (1100 beds, 5600 employees, 350 million euro budget/year). He has envisioned and implemented a revolutionary ' Big Data & Analytics Platform’ named 'HVITAL' that analyses 300 million patient records/day that automatically identifies and promptly alert to patients at risk in critical areas such as: clinical deterioration risk, infection control and antibiotic stewardship.

  • 12:20 - 13:00
    PANEL DISCUSSION - View from the ground - where are the opportunities to improve clinical practice and augment the healthcare professional? Dr. Indra Joshi, Clinical Lead - Digital Experience, Digital Urgent & Emergency Care, NHS England
    Dr. Navin Ramachandran, Radiology Consultant, University College London Hospitals NHS Foundation Trust
    Dr. Bart Geerts, Consultant Cardiac Anaesthetist, AMC & Founder, Healthplus.ai
    Moderator: Rosemary Rebuli, Global Head of Trial Management, Novartis

    Perspective from boots on the ground – clinical professionals who have been using AI based products share their views.

    • Dr. Indra Joshi, Clinical Lead - Digital Experience, Digital Urgent & Emergency Care, NHS England

      Dr Indra Joshi is clinical lead for NHS England’s digital experience programme. She has an overarching knowledge of the national patient-facing digital initiatives within the NHS with a focus on real world evidence, data and digital health tools standards. Indra has a unique portfolio with experience stretching across policy, governance, digital health and marketing, national project strategy and implementation; whilst remaining true to her professional training in emergency medicine. She is the Clinical Director of One HealthTech, a network which champions and supports underrepresented groups in health innovation, particularly women, to be the future leaders in healthcare. Indra, a mother-of-two, is also a Vice Chair for the British Computer Society (Health), an international speaker and consultant on digital health, an expedition medic.

    • Dr. Navin Ramachandran, Radiology Consultant, University College London Hospitals NHS Foundation Trust

      Dr. Navin Ramachandran is a practising radiology consultant at University College London Hospital, an honorary senior lecturer / healthcare data researcher at University College London Centre for Health Informatics & Multiprofessional Education and a co-founder of OpenCancer and the Platform for Enhanced Analytics and Computational Healthcare (PEACH).His main interests are in digital design, data modelling, interoperability, analytics, identity and consent management and he is also looking into the use of traditional blockchain in healthcare.

    • Dr. Bart Geerts, Consultant Cardiac Anaesthetist, AMC & Founder, Healthplus.ai

      Bart is the founder and CEO of Amsterdam startup Healthplus.ai with tools to predict depression relapse through mobile app use, readmissions for chronic heart failure for cardiologists via home monitoring, 3D bone segmentation for orthopaedic and trauma surgeons and in-hospital infections. He is an active physician and has over ten years of clinical experience as an anaesthetist, intensivist and clinical pharmacologist in the Netherlands and UK. He has managed a research group of more than ten scientists with a focus on medical technology and big data. Bart has years in Pharma and AI. He has worked on several innovation projects in hospital consortia regarding digital health. He has studied medicine (MD), biomedical sciences (MSc), intensive care medicine (PhD), and global business (MBA at IE University).

    • Moderator: Rosemary Rebuli, Global Head of Trial Management, Novartis

  • 13:00 - 14:00
    LUNCH & NETWORKING
  • STREAM 1A: AI IN R&D, CLINICAL TRIAL RESEARCH AND DRUG DISCOVERIES Babita Sharma, Television Presenter, BBC
    • 14:00 - 14:20
      TECH TALK - How to use AI methods to predict properties of potential drugs and their effects on hundreds of diseases Chris Gibson, Co-Founder and CEO, Recursion Pharma
      • Chris Gibson, Co-Founder and CEO, Recursion Pharma

        Chris Gibson, PhD, is the Co-Founder and CEO of Recursion Pharmaceuticals, a biotech company leveraging the latest in automation, artificial intelligence and biology to do drug discovery at scale. Chris developed the technology and approach underlying Recursion as part of his MD/PhD graduate work in the lab of Co-Founder Dr. Dean Li at the University of Utah. Chris left medical school to transform this technology into the rapidly growing company it is today. Chris is a graduate of Rice University with degrees in bioengineering and managerial studies, as well as a graduate of an intense entrepreneurship course at Stanford GSB. He is a Board Member of CureHHT, a patient advocacy group for Hereditary Hemorrhagic Telangiectasia, and a member of the Rare and Undiagnosed Network Advisory Board. Outside of work, Chris enjoys cycling on both the road and the trails that cut through Utah's great wilderness, as well as spending time with family.

    • 14:20 - 14:40
      CASE STUDY - Scaling and tackling the fundamental challenges in drug discovery by developing innovative AI technology Amir Saffari, SVP of AI, BenevolentAI
      • Amir Saffari, SVP of AI, BenevolentAI

        Amir Saffari has a PhD in Machine Learning and has been working in the field of Artificial Intelligence for more than 17 years, researching and developing ML theory, applications, and, products. He’s numerous publications in top-tier ML conferences and journals and most of his research has been released as open source software. He was part of Sony’s R&D team and has been involved in a few ML startups prior to joining BenevolentAI where he is currently leading the research and development of ML technology to drug discovery.

    • 14:40 - 15:00
      TECH TALK - Using speech recognition to quantify vocalytics of patients with cognitive disorders to understand their disease state and trajectory and improve clinical trial efficiency. Dr. Francesca Cormack, Director of Research and Innovation, Cambridge Cognition
      • Dr. Francesca Cormack, Director of Research and Innovation, Cambridge Cognition

        Francesca is Director of Research and Innovation at Cambridge Cognition. She has extensive experience of statistics, cognitive neuroscience and cognitive test development in a range of clinical populations. Since joining Cambridge Cognition in 2014, Francesca has worked to develop novel cognitive testing methodology to support high-frequency, near patient testing using digital technology, providing researchers and healthcare providers with unique insights into cognitive health. Francesca obtained a PhD in Dementia with Lewy Bodies at Newcastle University, followed by post-doctoral and academic positions at University College London and at the Medical Research Council in Cambridge. She maintains academic collaborations focused on neurological disorders, ageing and dementia.

    • 15:00 - 15:25
      CASE STUDY - The application value of AI for R&D, drug discovery, precision medicine and genomics Elena Bonfiglioli, Managing Director, Health and Life Sciences EMEA, Microsoft
      • Elena Bonfiglioli, Managing Director, Health and Life Sciences EMEA, Microsoft

    • 15:05 - 16:15
      STREAM 1B: AI IN KEEPING WELL AND PREVENTATIVE CARE Babita Sharma, Television Presenter, BBC
      • Babita Sharma, Television Presenter, BBC

        Babita Sharma is a BBC News presenter, regularly seen on the BBC News Channel, BBC World News, and presenting the show Newsday. Babita has presented the finance programme Your Money, and fronts business reports for BBC News. She has also covered economic and political stories from around the world.

    • 15:25 - 15:45
      CASE STUDY - Deep Patient - an unsupervised representation to predict the future of patients from their electronic health records Riccardo Miotto, Senior Data Scientist, Department of Genetics and Genomic Sciences, Icahn School of Medicine, Mount Sinai
      • Riccardo Miotto, Senior Data Scientist, Department of Genetics and Genomic Sciences, Icahn School of Medicine, Mount Sinai

    • 15:45 - 16:05
      TECH TALK - The workings of the first FDA-approved wearable to detect epileptic seizures and alert caregivers Matteo Lai, CEO and Co-Founder, Empatica
      • Matteo Lai, CEO and Co-Founder, Empatica

        Matteo Lai is co-founder and CEO of Empatica, a human data analytics company based in Milan and Boston. Empatica sells the world’s smallest and most accurate wearable sensor for research, and it recently launched Embrace, the first medical grade wearable designed to save lives for people with Epilepsy and Autism. He holds a Master in Innovation Management from Alta Scuola Politecnica

  • STREAM 2A: AI IN DECISION SUPPORT, TREATMENT AND DISEASE MANAGEMENT Chair: Alexander Finlayson, GP and Co-Founder, Nye, and Doll Fellow, Oxford University
    • 14:00 - 14:20
      CASE STUDY - Shaping the future of surgical care with data-driven AI and computer vision Dr. Andre Chow, Co-Founder, Digital Surgery
      • Dr. Andre Chow, Co-Founder, Digital Surgery

    • 14:20 - 14:40
      TECH TALK - Using AI and a patient centric model to provide a 'doctor in your pocket' and improve access to healthcare globally Daniel Nathrath, Co-Founder and CEO, Ada Health
      • Daniel Nathrath, Co-Founder and CEO, Ada Health

        Daniel has nearly 20 years’ experience leading the charge to bring transformational technology to new industries. During his career, he has founded and led several internet startups based in Denmark, Germany, the US and the UK. After studying law as a Fulbright Scholar at the University of Houston, Daniel earned his MBA at the University of Chicago, then shifted his focus to consulting at Boston Consulting Group before embarking on his entrepreneurial journey.

    • 14:40 - 14:50
      STARTUP STORY: UniversalDoctor Dr. Jordi Serrano Pons, General Practitioner & Founder, UniversalDoctor

      Hear from Intelligent Health’s pick of the best AI startups making waves in 2018.

      • Dr. Jordi Serrano Pons, General Practitioner & Founder, UniversalDoctor

    • 14:50 - 15:00
      TECH TALK - Using Big Data and AI to encourage healthier lifestyle solutions through a mobile app Manuel Heuer - COO, dacadoo
      • Manuel Heuer - COO, dacadoo

        Mr. Heuer joined dacadoo in 2011 as COO, signing responsible for sales, marketing and operations. From 2003 to 2011, he worked in various sales, business development & marketing roles with increasing management responsibilities in the medtech industry, first with Guidant Corp. in Belgium, France and Switzerland and then with St. Jude Medical as Managing Director of Switzerland from 2008 to 2011. From 1997 to 2001, Mr. Heuer held sales and marketing positions in the fast moving consumer goods industry with Nestlé in Brazil. Manuel Heuer holds an MBA from IMD International.

    • 15:00 - 15:05
      STARTUP STORY: Medicus Baher Al Hakim, CEO, Medicus

      Hear from Intelligent Health’s pick of the best AI startups making waves in 2018.

      • Baher Al Hakim, CEO, Medicus

        Baher Al Hakim is a dentist by study and a serial entrepreneur by practice, with 14 years experience in a broad spectrum of disciplines including product & technology, business, sales and marketing. Since June 2015, he is the CEO of Medicus AI, applying the latest technologies & trends in AI, mobile and design into redefining the state of healthcare. Before Medicus, he founded a number of startups, including CloudAppers digital agency in 2008, napkin startup studio in 2012, and Wally, a smart personal finance app that became no. 1 finance app in 22 countries.

    • 15:05 - 16:05
      STREAM 2B: AI IN EARLY DETECTION AND DIAGNOSTICS Maxine MacKintosh, Co-Founder, One HealthTech
      • Maxine MacKintosh, Co-Founder, One HealthTech

        Maxine Mackintosh is the co-founder of One HealthTech – a community which champions and supports underrepresented groups in health innovation, particularly women, to be the future leaders in healthcare. She does this alongside a data science PhD in London where she is mining medical records for new predictors of dementia. Her professional work has led her to the Royal Society, Roche, L’Oreal, Department for International Development, and NHS England. She is part of a number of communities and committees including the World Economic Forum’s Global Shapers, the British Computer Society and the Digital Health Forum. Maxine will moderate our stream on AI in mental health.

    • 15:05 - 15:25
      CASE STUDY - Applying advanced machine learning techniques to develop non-invasive blood tests to detect early-stage cancer and improve precision oncology Dr. Charles Roberts, Co-Founder and Chief Partnerships Officer, Freenome
      • Dr. Charles Roberts, Co-Founder and Chief Partnerships Officer, Freenome

        Dr. Charles Edward Selkirk Roberts, is a Co-Founder of Freenome Ltd nd has been its Executive Chairman since March 6, 2016. Dr. Roberts serves as the Partner at Loxbridge Research LLP. Previously, he was the Chief Executive Officer of the firm. Dr. Roberts is the Co-Founder of Loxbridge Research LLP. He served as a Project Management Principal at the firm. Dr. Roberts is a Founding Chief Executive Officer of greeenstar.org. He is a Founding Director and Chief Executive Officer of WZVI Ltd. He serves as the Chief Executive Officer of many of the Loxbridge projects such as Altermune. He serves as the President of Altermune Technologies LLC. He co-founded Premaitha Health and Search Lateral. Dr. Roberts founded Zoragen Biotechnologies. He began his career as a Doctor practicing reconstructive surgery in the United Kingdom. DR. Roberts served as the Chief Executive Officer of Freenome, LLC until March 6 2016. As a Doctor in the NHS previously, he worked on drug trials for large pharma, and earned Membership of the Royal College of Surgeons. He has worked in photography and film for Scotland on Sunday and Sunday Herald shot whilst a medical student. He organized clinical trials with Oxford University and others to develop innovative diagnostics and medical devices, including investigation of a non-invasive, non-X-Ray and low-cost electrical impedance imaging technology. He serves as Member of the Board of Directors at Loxbridge Research LLP. He serves as a Director of Agalimmune Limited. He served as a Non-Executive Director of Premaitha Health PLC (formerly, ViaLogy plc) since July 4, 2014 until July 6, 2016. Dr. Roberts won the 2011 Frost & Sullivan Growth, Innovation and Leadership Award, alongside co-awardee Richard Branson. He holds several patents for inventions in diverse fields. He is a doctor turned technology entrepreneur, inventor and investor. He has focused on his interests in developing beneficial technologies, both as for-profit and not-for-profit enterprises primarily in the healthcare space, and also in renewable energy/carbon. Dr. Roberts earned degrees in Medicine from the University of Dundee and in Psychology from University College London and a Masters at Oxford.

    • 15:25 - 15:30
      STARTUP STORY: Balzano
      Giuseppe Marbach, Lead Data Scientist for Medical Imaging, Balzano

      Hear from Intelligent Health’s pick of the best AI startups making waves in 2018.

      • Giuseppe Marbach, Lead Data Scientist for Medical Imaging, Balzano

        Giuseppe Marbach received his PhD degree in theoretical physics from the University of Basel in 1990, and was from 1990 to 1991 a post doctor at the Massachusetts Institute of Technology, Cambridge. Since 1992, he worked for several private companies as a research scientist and developed algorithms for image and video content analysis (objects recognition and tracking in video). In the last years, he focused his interest in Deep Neural Networks for visual recognition. He joined 2017 Balzano Informatik, where he is currently the lead data scientist for medical images.

    • 15:30 - 15:50
      TECH TALK - Using AI and machine learning to identify febrile illnesses in children in Tanzania and rationalise the use of antimicrobials Prof. Valérie D'Acremont - Clinical Epidemiologist, The Swiss Tropical and Public Health Institute, University Hospital of Lausanne
      • Prof. Valérie D'Acremont - Clinical Epidemiologist, The Swiss Tropical and Public Health Institute, University Hospital of Lausanne

        Valérie D’Acremont is a clinical epidemiologist at the Swiss TPH and one of the nine Pfizer Research Prize 2015 awardees for her paper on febrile illnesses published in the New England Journal of Medicine. The prize is one of the most prestigious awards in Switzerland for a single research paper. Prof. Acremont led the research team from the Swiss Tropical and Public Health Institute in Basel and the Policlinique Médicale Universitaire in Lausanne where the causes of febrile illnesses in Tanzanian children was systematically assessed. Prof. Acremont got her PhD in Epidemiology and a Masters in International Health from the University of Basel, Switzerland. Prof. Acremont also received a Doctorate of Medicine from the University of Lausanne in Switzerland.

    • 15:50 - 15:55
      STARTUP STORY: Skychain Alexander Chub, Chief Strategy Officer, Skychain

      Hear from Intelligent Health’s pick of the best AI startups making waves in 2018.

      • Alexander Chub, Chief Strategy Officer, Skychain

        Professional with 20+ years of experience in development of complex software projects in hybrid platforms. During his career, he has taken part in all of the stages of software development cycle providing best industry practices to the team. Also, Alexander has an extensive expertise in neural network development and deep machine learning. Right now he is a part of the Skychain team, where he works as a Chief Strategist.

    • 15:55 - 16:05
      STARTUP TECH TALK: Using AI to improve the diagnosis of the most deadly infectious diseases in remote communities Eduardo Peire, CEO, AI Scope
      • Eduardo Peire, CEO, AI Scope

        Eduardo Peire is the CEO of AI Scope. Ai Scope Uses Machine Learning, more specifically Deep learning (Neural networks) to create a computer vision system to diagnose Malaria. It is cheap, accurate and super portable. The project is divided in 2 parts: ► A Open Source microscope what works with cellphones and webcams, to take a picture of the blood sample. ► And a web and app based software to diagnose if the blood sample has malaria.

  • 16:05 - 16:35
    REFRESHMENTS & NETWORKING
  • 16:05 - 16:35
    AFTERNOON PLENARY: ETHICS IN THE AGE OF AI IN HEALTHCARE
  • 16:35 - 17:00
    HEADLINER - Introducing Explainable AI (XAI): why XAI holds the key to unlocking performance Simon Williams, Co-Founder, QuantumBlack, a McKinsey Company
    • Simon Williams, Co-Founder, QuantumBlack, a McKinsey Company

      Simon founded QuantumBlack to help clients improve asset, operations and human performance by applying new intelligence gained from data, advanced analytics and visualisation. He provides Board-level expertise to leading organisations around the world, blending strategy, analytics, engineering and design to help solve the most challenging problems. The impact can be transformational, changing the way business is done.

  • 17:00 - 17:25
    HEADLINER - How should we define new digital ethics which includes the benefits of technology for society and the economy whilst reinforcing the rights and freedoms of individuals? Professor Luciano Floridi, Professor of Philosophy and Ethics of Information, University of Oxford and Director, Digital Ethics Lab
    • Professor Luciano Floridi, Professor of Philosophy and Ethics of Information, University of Oxford and Director, Digital Ethics Lab

      Floridi is deeply engaged with emerging policy initiatives on the socio-ethical value and implications of digital technologies and their applications. And he has worked closely on digital ethics (including the ethics of algorithms and AI) with the European Commission, the German Ethics Council, and, in the UK, with the House of Lords, the Cabinet Office, and the Information Commissioner’s Office, as well as with multinational corporations (e.g. Cisco, Google, IBM, Microsoft, and Tencent). Currently, he is a Member of the EU’s Ethics Advisory Group on Ethical Dimensions of Data Protection, of the Royal Society and British Academy Working Group on Data Policy, of Google Advisory Board on “the right to be forgotten”, of the Advisory Board of Tencent’s Internet and Society Institute, and of NEXA’ Board of Trustees. He is the Chairman of the Ethics Advisory Board of the European Medical Information Framework (a €56 million EU project on medical informatics).

  • 17:25 - 17:55
    HEADLINER PANEL DISCUSSION - Healthcare ethics in the AI revolution Prof. Effy Vayena, Professor, ETH Zurich
    Dr. Farzana Rahman, Consultant Radiologist UCLH and Clinical Advisor, Data and Digital Strategy Lead, NHS Digital and The Academy of Medical Royal Colleges
    Alessandro Curioni, IBM Fellow, Vice President Europe and Director, IBM Research
    Moderator: Dr. Bart Geerts, Consultant Cardiac Anaesthetist, AMC & Founder, Healthplus.ai

    – Protection: How can human subjects and their data be protected
    – Responsibility: Who or what is responsible if things go wrong?
    – Liability: How do you measure the acceptable level of responsibility and liability for the players in AI?

    • Prof. Effy Vayena, Professor, ETH Zurich

      The Health Ethics and Policy Lab focuses on ethical and policy challenges in precision medicine and digital health. The advances in genomics, omics and data intensive research, have brought medicine and healthcare to an inflection point. Such progress holds great promise for improving individual and population health, while also presenting unprecedented ethical and regulatory challenges in areas such as privacy, individual freedom and risk policy. In order to harness the full potential of those novel approaches in health care, robust ethical policies are needed to resolve novel and pressing issues. At the lab, we identify and tackle the key ethical, legal and societal implications (ELSI) of precision medicine and digital health. The complexity of these questions calls for an interdisciplinary approach to research in bioethics and health policy, which is why, our team has expertise in philosophy, social science, clinical medicine, public health, data science, health policy, law.

    • Dr. Farzana Rahman, Consultant Radiologist UCLH and Clinical Advisor, Data and Digital Strategy Lead, NHS Digital and The Academy of Medical Royal Colleges

      Dr Farzana Rahman splits her time as a Consultant Radiologist at University College London Hospital and Clinical Advisor at NHS Digital. She is also the lead for Digital Strategy at the Academy of Medical Royal Colleges - specifically looking at the impact of AI and leading on these projects.

    • Alessandro Curioni, IBM Fellow, Vice President Europe and Director, IBM Research

      Dr. Alessandro Curioni is an IBM Fellow, Vice President of IBM Europe and director of the IBM Research Lab in Zurich, Switzerland. He was also recently appointed as the Watson IoT Research Relationship Executive.

    • Moderator: Dr. Bart Geerts, Consultant Cardiac Anaesthetist, AMC & Founder, Healthplus.ai

      Bart is the founder and CEO of Amsterdam startup Healthplus.ai with tools to predict depression relapse through mobile app use, readmissions for chronic heart failure for cardiologists via home monitoring, 3D bone segmentation for orthopaedic and trauma surgeons and in-hospital infections. He is an active physician and has over ten years of clinical experience as an anaesthetist, intensivist and clinical pharmacologist in the Netherlands and UK. He has managed a research group of more than ten scientists with a focus on medical technology and big data. Bart has years in Pharma and AI. He has worked on several innovation projects in hospital consortia regarding digital health. He has studied medicine (MD), biomedical sciences (MSc), intensive care medicine (PhD), and global business (MBA at IE University).

  • 17:55 - 18:05
    CLOSE OF SUMMIT DAY ONE
  • 18:15 - 20:00
    NETWORKING DRINKS WITH NOVARTIS - Future of Life Sciences with AI Achim Plueckebaum - Global Head, Drug Development IT, Novartis
    • Achim Plueckebaum - Global Head, Drug Development IT, Novartis

  • Thursday 13th
  • 08:00 - 09:00
    REGISTRATION
  • 09:00 - 10:35
    MORNING PLENARY: AI IN GLOBAL HEALTH, DEVELOPING ECONOMY HEALTH AND FOR MONITORING HEALTH EPIDEMICS
  • 09:15 - 09:25
    WELCOME Babita Sharma, Television Presenter, BBC
    • Babita Sharma, Television Presenter, BBC

      Babita Sharma is a BBC News presenter, regularly seen on the BBC News Channel, BBC World News, and presenting the show Newsday. Babita has presented the finance programme Your Money, and fronts business reports for BBC News. She has also covered economic and political stories from around the world.

  • 09:25 - 09:50
    HEADLINER - Technology data analysis and AI for outbreak preparedness and response Dr. Oliver Morgan, Director of Health Emergency and Risk Assessment - WHO Health
    • Dr. Oliver Morgan, Director of Health Emergency and Risk Assessment - WHO Health

      Dr. Oliver Morgan is the Director of the Health Emergency Information and Risk Assessment Department in the WHO Health Emergencies Program. From 2007 through 2016, Dr. Morgan worked for the US Centers for Disease Control and Prevention during which time he held critical leadership positions in the Ebola response between November 2014 and February 2016 (CDC Atlanta Ebola Response Incident Manger and CDC Country Director in Sierra Leone).

  • 09:50 - 10:15
    HEADLINER: Data + Intelligence – the corner stones of next generation Life Sciences Anne O’Riordan, Senior Managing Director, Accenture Life Sciences
    • Anne O’Riordan, Senior Managing Director, Accenture Life Sciences

      Anne is the global Industry Senior Managing Director for Accenture’s Life Sciences business and a global client lead. She has been with Accenture for 28 years. Over this period she has worked across the US, Europe and Asia with global companies transforming their business and operating models, to meet changing market and portfolio needs. She has been in China since 2007 and has been on the board of the global Products Operating Group of Accenture since 2006. She has published numerous articles over the past 20+ years. Her most recent publication is a book entitled ‘Healthcare Disrupted: Next Generation Business Models and Strategies@ (Wiley Feb 2016)”. Based in Hong Kong, Ms. O’Riordan is a member of The Women’s Foundation, the 30% Club and co-chair of the Women of Influence Committee at the American Chamber of Commerce.

  • 10:15 - 10:55
    PANEL DISCUSSION - Using big data and machine learning models to understand developing economy health, humanitarian aid and how epidemics spread. Jay Komarneni, Founder and Chair, Human Diagnosis Project
    Ting Shih, CEO & Founder, ClickMedix
    Dr. Ian Norton, Project Lead - Emergency Medical Teams, World Health Organization
    Clara Palau, Technology Lead, Office of Innovation, UNICEF
    Huguette Diakabana, Co-Founder and Deputy Director, African Alliance of Digital Health Networks
    Moderator: Joel Myhre, Humanitarian Technology Innovator

    Panel Moderator: Joel Myhre, Humanitarian Technology Innovator, Ada-AI

    • Jay Komarneni, Founder and Chair, Human Diagnosis Project

      Jay Komarneni is Chair of the Human Diagnosis Project. Previously, Jay advised preeminent organizations at McKinsey & Company and Bain & Company, helped launch and operate a global alternative investment firm, and participated in Y Combinator, the top technology accelerator. Jay has been recognized as a Thouron Scholar, a Luce Scholarship recipient, a Rhodes Scholarship finalist, an MIT Technology Review Innovators under 35 semifinalist, and by the MacArthur Foundation for leading one of eight organizations globally with a bold solution to a critical social problem. Academically, Jay completed five degrees in six years at Oxford and Penn before enrolling in the M.D. program at Johns Hopkins (which he ultimately did not attend).

    • Ting Shih, CEO & Founder, ClickMedix

      ClickMedix is a global mobile health (mHealth) social enterprise founded by faculty and students from Massachusetts Institute of Technology (MIT) and Carnegie Mellon University to increase capacity of physicians and health organizations to serve more patients. By enabling existing medical experts to serve more patients, they can address the following global healthcare challenges: - Lack of access: Patients cannot easily reach doctors. - Lack of funds: Patients cannot afford the high cost of healthcare, and governments/NGOs are unable to subsidize under-served populations entirely -Lack of medical resources: Most countries face severe shortages of trained healthcare professionals, especially medical specialists They bring affordable and quality health services to under-served patients, by enabling health organizations to reach more patients through mobile phone/tablet facilitated remote diagnosis using AI as well as remote training and supervision of their staff assistants, nurses, and health workers.

    • Dr. Ian Norton, Project Lead - Emergency Medical Teams, World Health Organization

      Dr. Norton is an Emergency Physician with post graduate qualifications in International Health, Tropical Medicine and Surgery and works for the World Health Organization HQ in Geneva heading the new Emergency Medical Team Unit. He is the lead author of the WHO Global classification and standards for Foreign Medical Team (FMT) deployment to sudden onset disasters which led to his appointment to the WHO leading the development of a global registry of EMTs and the increasing role of WHO in their quality assurance and coordination. He will share his perspective on WHO is using big data and machine learning models to understand developing economy health, humanitarian aid and how epidemics spread.

    • Clara Palau, Technology Lead, Office of Innovation, UNICEF

      Clara Palau leads the technology team at UNICEF’s Office of Innovation, a group focused on using data cience and artificial intelligence to support humanitarian and development programmes for the most vulnerable children, by enabling partnerships through private sector, academia and public organisations. She works on combining data science and real-time data to develop new tools empowering UNICEF for a faster and more effective response in health emergencies and will share how UNICEF is using big data and machine learning models to understand developing economy health, humanitarian aid and how epidemics spread.

    • Huguette Diakabana, Co-Founder and Deputy Director, African Alliance of Digital Health Networks

      Huguette has a demonstrated history of working with international organizations and governments. She is passionate about fostering collaboration and expanding access to impactful knowledge. Her primary goal is to leverage technology to achieve meaningful progress, in sub-Saharan Africa. Her experiences include developing and implementing context appropriate technology-based solutions. She has worked on projects in education, mining, environment, agriculture, and health in over 20 countries. Huguette also mentors students and young professionals interested in collaboration and in leveraging appropriate, sustainable, and cost-effective technologies to make a difference in their communities. She currently lives in Ouagadougou, Burkina Faso and travels to countries in Central and West Africa to conduct policy and strategy development sessions.

    • Moderator: Joel Myhre, Humanitarian Technology Innovator

      Furthering the all-hazards art of the possible via Artificial Intelligence, Machine Learning, and Joel has a passion for working in the space of saving lives via humanitarian innovation.

  • 10:55 - 11:35
    REFRESHMENTS & NETWORKING
  • STREAM 1A: AI IN GENOMICS AND PRECISION/PERSONALISED MEDICINE Babita Sharma, Television Presenter, BBC
    • 11:35 - 11:55
      CASE STUDY - AI-enable hyperpersonalized oncology care Dr. Mimi Huizinga, Vice President, Strategic Data and Digital, US Oncology, Novartis
      • Dr. Mimi Huizinga, Vice President, Strategic Data and Digital, US Oncology, Novartis

        Mary Margaret (“Mimi”) Huizinga, MD MPH FACP, is the Vice President, Strategic Data and Digital for US Oncology at Novartis. Dr. Huizinga leads the digital and data strategies and supports the broader digital, data and real world evidence needs for US Oncology. In addition, she oversees the generation and dissemination of value evidence at Novartis through the work of the HEOR (health economics and outcomes research) team.

    • 11:55 - 12:15
      TECH TALK - How can advances in vital signs monitoring technology combine with AI provide a continuous stream of analysed data to the medical professional? Dr Adrian Attard Trevisan, Co-Founder and CEO, Umana Medical Technologies
      • Dr Adrian Attard Trevisan, Co-Founder and CEO, Umana Medical Technologies

        Dr Adrian Attard Trevisan is a research fellow of the Bedfordshire Center for Mental Health Research in association with the University of Cambridge. He is also an entrepreneur, having founded and acted as Chief Executive Officer and Chief Scientific Officer of AAT Research – now Neurotech International – a publicly listed company on the Australian Securities Exchange (ASX). Currently he is co-founder and Chief Executive Officer of Umana Medical Technologies, which offers innovative clinical-grade solutions for long-term monitoring of physiological parameters complemented with an ecosystem of clinical grade software, hardware and artificial neural algorithms that ensures the highest quality and reliability of data gathered and analysed.

    • 12:15 - 12:35
      TECH TALK - Utilising AI-guided simulated experiments to increase laboratory success rates and reduce time to trial Dr. Dániel Veres, Chief Medical Officer, Turbine
      • Dr. Dániel Veres, Chief Medical Officer, Turbine

        Dániel is the creator of the first compartmentalized protein-protein interaction database, with years of experience building computational models in order to understand the behaviour of human cells. As a medical doctor, Daniel translates computational results into clinical interpretations, indispensable to design innovative and relevant treatments to defeat cancer.

    • 12:35 - 12:55
      CASE STUDY - Project MURAB: Using AI to take more precise and effective biopsies in order to diagnose cancer Professor Stefano Stramigioli, Project Leader- MURAB, University of Twente
      • Professor Stefano Stramigioli, Project Leader- MURAB, University of Twente

  • STREAM 2A: AI IN CHILD HEALTH Stefan Germann, CEO, Fondation Botnar
    • 11:35 - 11:55
      CASE STUDY - Using AI and smart phenotyping to help diagnose rare diseases in children Dr. Andrea Superti-Furga, Head of Genetic Medicine, Lausanne University Hospital
      • Dr. Andrea Superti-Furga, Head of Genetic Medicine, Lausanne University Hospital

        Andrea Superti-Furga has obtained his medical degrees at the Universities of Genoa and Zurich and certification in Pediatrics in Italy and Switzerland. His mentors were Professors Paolo Durand, Victor McKusick, Andrea Prader, Andres Giedion, Richard Gitzelmann, Beat Steinmann and Sergio Fanconi. He developed a research activity on inborn diseases in Zurich and then in New York with Prof. Francesco Ramirez. In 2002, he was appointed Professor for Molecular Pediatrics at the University of Lausanne; in 2004, Chairman of the Department of Pediatrics at the University of Freiburg, Germany; in October 2010 he was awarded the Leenaards Chair of Excellence in Pediatrics at the University of Lausanne. In 2014 and 2015 he was Director of the Department of Pediatrics in Lausanne. Since 2016 he is Professor and Head of the Division of Genetic Medicine at the University Hospital in Lausanne, Switzerland, that includes a clinical section as well as a diagnostic laboratory for cytogenetics and molecular genetics.

    • 11:55 - 12:35
      PANEL DISCUSSION - AI, adolescents and universal health coverage Siddartha Jha, AI Digital Program Manager, Fondation Botnar
      Noni Gachuhi, Women's Health Team Lead, Intellectual Ventures
      Dismus Masheti, Chief Marketing Officer, ConnectMed
      Moderator: Prof. Effy Vayena, Professor, ETH Zurich
      • Siddartha Jha, AI Digital Program Manager, Fondation Botnar

        Siddartha Jha is the AI/Digital Program Manager for Fondation Botnar. He grew up in India where he completed his Bachelor in Engineering degree at the Indian Institute of Technology, Kanpur. He gained many years of experience in Research and Development projects in technology and the healthcare industry, with a focus on mobile phones and hearing devices. He holds an MSc. in Biomedical Engineering and a CAS in Computer Science with a focus on AI and information systems, both from ETH Zurich.

      • Noni Gachuhi, Women's Health Team Lead, Intellectual Ventures

        Noni Gachuhi has been working in public health for over 18 years, designing and delivering health programs for reproductive health, malaria, and HIV prevention across Africa and Asia. In her current role at Global Good/ Intellectual Ventures, she oversees a portfolio of products intended for use at primary health care in low resource settings.

      • Dismus Masheti, Chief Marketing Officer, ConnectMed

        Dismus Masheti is Chief Marketing Officer at ConnectMed, a Kenya-focused telehealth platform that allows you to video consult a doctor anytime, anywhere. ConnectMed has recently expanded into chronic disease management and wellness, and our platform is specifically designed for the African context; we offer low cost, on-demand doctor consults over video along with other essential healthcare services through intelligent technology solutions. Healthcare is a fundamental human right, and therefore should be accessed conveniently at an affordable cost.

      • Moderator: Prof. Effy Vayena, Professor, ETH Zurich

    • 12:35 - 12:55
      TECH TALK - Using deep-learning tools to allow parents, coaches and medics to detect concussion and brain injuries with a smartphone app Dr. Lynn McGrath, Resident Physician, Neurological Surgery, University of Washington and Co-Founder, PupilScreen
      • Dr. Lynn McGrath, Resident Physician, Neurological Surgery, University of Washington and Co-Founder, PupilScreen

  • 12:55 - 13:55
    LUNCH & NETWORKING
  • STREAM 1B: AI for health Babita Sharma, Television Presenter, BBC
    • 13:55 - 14:55
      PANEL DISCUSSION - AI for health Prof. Thomas Wiegand, Executive Director, Fraunhofer HHI
      Prof. Marcel Salathé, Associate Professor, EPFL
      Dr. Ramesh Krishnamurthy, Senior Advisor - Health Information Systems and Digital Health, World Health Organisation
      Dr. Ann Aerts, Head, Novartis Foundation
      Hani Eskandar, ICT Applications Coordinator, International Telecommunication Union
      Moderator: Stefan Germann, CEO Fondation Botnar
      • Prof. Thomas Wiegand, Executive Director, Fraunhofer HHI

        Thomas Wiegand is a professor in the department of Electrical Engineering and Computer Science at the Technical University of Berlin and is jointly heading the Fraunhofer Heinrich Hertz Institute, Berlin, Germany. He received the Dipl.-Ing. degree in Electrical Engineering from the Technical University of Hamburg-Harburg, Germany, in 1995 and the Dr.-Ing. degree from the University of Erlangen-Nuremberg, Germany, in 2000. The projects that he co-chaired for the development of the H.264/MPEG-AVC standard have been recognized by an ATAS Primetime Emmy Engineering Award. He was also a recipient of a ATAS Primetime Emmy Engineering Award for the development of H.265/MPEG-HEVC and a pair of NATAS Technology & Engineering Emmy Awards.

      • Prof. Marcel Salathé, Associate Professor, EPFL

        Marcel Salathé is a digital epidemiologist working at the interface of population biology, computational sciences, and the social sciences. He obtained his PhD at ETH Zurich and spent two years as a postdoc in Stanford before joining the faculty at Penn State in 2010 at the Center for Infectious Disease Dynamics. In 2014, he spent half a year at Stanford as visiting assistant professor. In the summer of 2015, Marcel became an Associate Professor at EPFL where he heads the Digital Epidemiology Lab at the new Campus Biotech. In 2016, he has also been appointed Academic Director of EPFL Extension School, whose mission is to provide high quality online education in digital technology.

      • Dr. Ramesh Krishnamurthy, Senior Advisor - Health Information Systems and Digital Health, World Health Organisation

        Dr. Krishnamurthy serves as a senior advisor for health information systems and digital health at the World Health Organization in Geneva, Switzerland. He has extensive experience in designing, implementing, coordinating, and managing national and subnational eHealth systems and services, including health information systems, emergency operations centers, and public health surveillance information systems. Dr. Krishnamurthy has also assisted numerous countries in all of the six WHO Regions in their development and implementation of national and sub-national eHealth strategies, standardization and interoperability of eHealth systems and services, and utilization of strategic information for evidence-based public health decision-making. Previously Dr. Krishnamurthy served as Senior Informatics Advisor at the United States Centers for Disease Control and Prevention (CDC) in Atlanta. He holds many prestigious honors and awards.

      • Dr. Ann Aerts, Head, Novartis Foundation

        Dr. Ann Aerts has been Head of the Novartis Foundation since January 2013, where she has played a key role in devising new policy recommendations. She has the exciting responsibility of heading an organization committed to exploring innovative solutions to public health problems. The Novartis Foundation has the challenging goals of expanding access to quality healthcare and eliminating diseases such as leprosy and malaria. Before her current role, Ann was Franchise Medical Director Critical Care for Novartis Pharma in Basel and Therapeutic Area Head Cardiovascular and Metabolism in Novartis Pharma Belgium. Prior to joining Novartis, she served as Director of the Lung and Tuberculosis Association in Belgium, as Head of the Health Services Department of the International Committee of the Red Cross (ICRC) in Geneva and was Health Coordinator for the ICRC in several countries.

      • Hani Eskandar, ICT Applications Coordinator, International Telecommunication Union

        Mr. Eskandar is the ICT Applications Coordinator at the ICT Applications and Cybersecurity Division of the Telecommunication Development Bureau of ITU. Mr. Eskandar is currently involved in providing assistance to several developing countries by advising on eApplications strategies and policies, assisting in implementing technical cooperation projects in areas of digital health, agriculture, governance and education. He has lead the development of several guidelines and best-practices reports on eApplications. Previously, Mr. Eskandar had extensive experience in the field of ICT for Development where he, through working with the International Federation of Red Cross and Red Crescent in Switzerland and, UNDP and other NGOs in Egypt, was involved in several development projects in the fields of Health, Education, Illiteracy Eradication, Community Development, SME development and Micro Credits. This included, among others, introducing Telemedicine services in rural areas, introducing ICT in Schools, creating Community Development Portals, Community Learning Centres, developing e-Learning and training programs for Youth.

      • Moderator: Stefan Germann, CEO Fondation Botnar

        Stefan German, CEO, Fondation Botnar. Fondation Botnar is a Swiss foundation established in 2003 with the core purpose of improving the health and wellbeing of children and young people in growing secondary cities around the world. Stefan is tasked as first CEO to set up the management office and lead the foundation in the next stage of it's development. Fondation Botnar is joining Intelligent Health to promote the importance of AI for child health and wellbeing. The foundation is hosting a panel discussion to highlight key uses of AI in health assessments, disease prevention and promotion of wellbeing, with a focus on the opportunities, challenges and equity in healthcare for children and adolescents.

  • STREAM 2B: AI under the hood: Norvatis Workshop
    • 13:55 - 15:25
      WORKSHOP - Patient data for analytics and AI Raj Patil, Head of Data Strategy, Novartis
      Peter Speyer - Global Head of Development Portfolio, Medical, Digital and RWE Solutions, Novartis

      Most health data currently exist in siloes, collected by providers, payers, pharma, digital health companies and others in many different standards, formats and systems. Exchanging data or analyzing data to advance understanding of health and effectiveness of interventions requires time-consuming data wrangling and preparation.

      A number of standards have emerged that make this task easier, e.g. HL7 FIHR, OMOP CDM, CDisc, schema.org. Analyses are supported by increasingly sophisticated approaches to protect patient privacy, e.g. risk-based anonymization, federated analytics, or analytics on encrypted data. Another powerful and privacy-compliant way to link and share data is at the patient level, where control over the data sits with the patient. Initiatives like MIDATA, healthbank, OoNiDa and others are building on this philosophy.

      In this workshop, we will explore ways to increase availability and quality of data for advanced analytics and AI while improving data governance, and aim to develop a vision for the future of data sharing and AI with an empowered patient.

      • Raj Patil, Head of Data Strategy, Novartis

      • Peter Speyer - Global Head of Development Portfolio, Medical, Digital and RWE Solutions, Novartis

  • 14:55 - 15:30
    REFRESHMENTS & NETWORKING
  • 14:55 - 15:30
    AFTERNOON PLENARY: FUTURE GAZING
  • 15:30 - 15:50
    TECH TALK - Commercialising the science of ageing biology Jay Olshansky, Co-Founder and Chief Science Officer, Lapetus
    • Jay Olshansky, Co-Founder and Chief Science Officer, Lapetus

      Lapetus, a US-based start-up can scan the picture of a person and by analysing thousands of different regions of the face, looking not just for basic information such as gender but for clues about how quickly the person is ageing, their body mass index and whether they smoke - can predict life expectancy. Armed with this and other information from customers, the computers come up with what Lapetus says is a far more accurate prediction of life expectancy than traditional methods can provide. And the whole process takes only a few minutes. Jay will share his views on how they do this - and how the advance of technology and the potential for artificial intelligence to revolutionise the way this information can be used my the insurance industry.

  • 15:50 - 16:15
    HEADLINER Deep learning for health – what’s still missing? Gary Marcus, Professor of Psychology and Neural Science, New York University
    • Gary Marcus, Professor of Psychology and Neural Science, New York University

      Gary Marcus, scientist, bestselling author, entrepreneur, and AI contrarian, was CEO and Founder of the machine learning startup Geometric Intelligence, recently acquired by Uber. As a Professor of Psychology and Neural Science at NYU, he has published extensively in fields ranging from human and animal behavior to neuroscience, genetics, and artificial intelligence, often in leading journals such as Science and Nature. He is launching a startup focusing on artificial general intelligence focusing on healthcare.

  • 16:15 - 16:35
    TECH TALK - Using a wearable AI system to detect conversational tone and act as a “social coach” for people with anxiety or Asperger’s Mohammad Ghassemi, Co-Founder, Ghamut Corporation
    • Mohammad Ghassemi, Co-Founder, Ghamut Corporation

      Mohammad Ghassemi is an award winning scholar and entrepreneur. He holds a Ph.D from the Massachusetts Institute of Technology in computer science with a focus on artificial intelligence, and a minor in institutional communications. He is regarded for his work in creating the world’s largest open access intensive care database, a wearable A.I. for social coaching and a rapidly growing platform that connects thousands of students for face-to-face meetings at six universities across the US.

  • 16:35 - 16:55
    ANA AVATAR XPRIZE COMPETITION - XPRIZE and AI + Health: A path forward Amir Banifatemi, AI Lead, XPRIZE
    • Amir Banifatemi, AI Lead, XPRIZE

      Amir Banifatemi has more than 25 years of experience in development and growth of emerging and transformative technologies. At XPRIZE he is the Prize Lead of the IBM Watson AI XPRIZE and has launched the Cancer XPRIZE goal. The winning Cancer XPRIZE team will develop scalable and culturally sensitive solutions to rapidly, accurately, and affordably screen for early cancers where intervention can reduce human suffering - a part of this launch will be at Intelligent Health this year.

  • 16:55 - 17:20
    CLOSING HEADLINER - How tech giants are moving into healthcare Nikhil Krishnan, Senior Industry Analyst, CB Insights
    • Nikhil Krishnan, Senior Industry Analyst, CB Insights

      Nikhil Krishnan is a senior analyst at CB Insights, where he produces data-driven analysis and research reports on trends in digital health, ag tech, and construction. He sends the weekly Digital Health Insights newsletter to 30K+ members. His research has been featured in The Economist, New York Times, Wall Street Journal, and more. Prior to joining CB Insights, Nikhil worked at Uber, the Small Business Administration, and Relationship Science.

  • 17:20 - 17:30
    CLOSE OF INTELLIGENT HEALTH